Log in

NASDAQ:LMNXLuminex Stock Price, Forecast & News

$26.79
-1.36 (-4.83 %)
(As of 04/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$26.50
Now: $26.79
$28.79
50-Day Range
$23.09
MA: $25.60
$28.85
52-Week Range
$17.34
Now: $26.79
$30.90
Volume450,058 shs
Average Volume637,916 shs
Market Capitalization$1.21 billion
P/E RatioN/A
Dividend Yield1.28%
Beta0.46
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; and VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges, as well as operates as an original equipment manufacturer of custom reagents and instrumentation. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.
Read More
Luminex logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 2.0Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.51 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryLife Sciences Tools & Services
SectorMedical
Current SymbolNASDAQ:LMNX
CUSIP55027E10
Phone512-219-8020

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$334.64 million
Cash Flow$0.41 per share
Book Value$10.32 per share

Profitability

Net Income$-3,840,000.00

Miscellaneous

Employees1,247
Market Cap$1.21 billion
Next Earnings Date5/4/2020 (Estimated)
OptionableOptionable

Receive LMNX News and Ratings via Email

Sign-up to receive the latest news and ratings for LMNX and its competitors with MarketBeat's FREE daily newsletter.


Luminex (NASDAQ:LMNX) Frequently Asked Questions

How has Luminex's stock been impacted by COVID-19 (Coronavirus)?

Luminex's stock was trading at $27.11 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LMNX stock has decreased by 1.2% and is now trading at $26.79. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Luminex?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Luminex in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Luminex.

When is Luminex's next earnings date?

Luminex is scheduled to release its next quarterly earnings announcement on Monday, May 4th 2020. View our earnings forecast for Luminex.

How were Luminex's earnings last quarter?

Luminex Co. (NASDAQ:LMNX) issued its quarterly earnings results on Monday, February, 10th. The medical instruments supplier reported $0.07 EPS for the quarter, beating the Zacks' consensus estimate of ($0.01) by $0.08. The medical instruments supplier earned $90.50 million during the quarter, compared to analysts' expectations of $90.27 million. Luminex had a negative return on equity of 2.03% and a negative net margin of 1.18%. The firm's quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.04 earnings per share. View Luminex's earnings history.

How often does Luminex pay dividends? What is the dividend yield for Luminex?

Luminex announced a quarterly dividend on Tuesday, February 18th. Stockholders of record on Thursday, March 19th will be paid a dividend of $0.09 per share on Thursday, April 9th. This represents a $0.36 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date of this dividend is Wednesday, March 18th. View Luminex's dividend history.

What guidance has Luminex issued on next quarter's earnings?

Luminex issued an update on its first quarter 2020 After-Hours earnings guidance on Monday, February, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $82-84 million, compared to the consensus revenue estimate of $87.74 million.

What price target have analysts set for LMNX?

3 analysts have issued 12 month target prices for Luminex's shares. Their forecasts range from $21.00 to $32.00. On average, they anticipate Luminex's stock price to reach $26.50 in the next year. This suggests that the stock has a possible downside of 1.1%. View analysts' price targets for Luminex.

Has Luminex been receiving favorable news coverage?

Media coverage about LMNX stock has trended very negative on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Luminex earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutLuminex.

Who are some of Luminex's key competitors?

What other stocks do shareholders of Luminex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Luminex investors own include Baidu (BIDU), Micron Technology (MU), AbbVie (ABBV), Pfizer (PFE), Verizon Communications (VZ), Alphabet (GOOG), Starbucks (SBUX), AT&T (T), Exxon Mobil (XOM) and Gilead Sciences (GILD).

Who are Luminex's key executives?

Luminex's management team includes the following people:
  • Mr. Nachum Shamir, CEO, Pres & Director (Age 65)
  • Mr. Harriss T. Currie, CFO, Sr. VP of Fin. & Treasurer (Age 57)
  • Mr. Richard W. Rew II, Sr. VP, Gen. Counsel & Corp. Sec. (Age 51)
  • Mr. Todd C. Bennett, Sr. VP of Global Sales & Customer Operations (Age 49)
  • Mr. Randall J. Myers, Sr. VP of Global Manufacturing & Quality (Age 57)

What is Luminex's stock symbol?

Luminex trades on the NASDAQ under the ticker symbol "LMNX."

How do I buy shares of Luminex?

Shares of LMNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Luminex's stock price today?

One share of LMNX stock can currently be purchased for approximately $26.79.

How big of a company is Luminex?

Luminex has a market capitalization of $1.21 billion and generates $334.64 million in revenue each year. The medical instruments supplier earns $-3,840,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis. Luminex employs 1,247 workers across the globe. View additional information about Luminex.

What is Luminex's official website?

The official website for Luminex is http://www.luminexcorp.com/.

How can I contact Luminex?

Luminex's mailing address is 12212 TECHNOLOGY BLVD, AUSTIN TX, 78727. The medical instruments supplier can be reached via phone at 512-219-8020 or via email at [email protected]

This page was last updated on 4/4/2020 by MarketBeat.com Staff

Featured Article: Derivative

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel